Materials and methods
We employed Sinefungin as a lead structure for the design and synthesis of a series of methyltransferase inhibitors and tested them for inhibition of EHMT1/2. The α-amino acid moiety of Sinefungin was exchanged to obtain two different series of compounds-one with the additional amino group and one without amino group. Screening of compounds were done by using a FRET-based LANCE ultra G9a histone H3-Lysine N-methyltransferase assay [3] that measures the dimethylation of a biotinylated histone H3 (1-21) peptide at lysine 9.
Results
A series of analogues of the natural product Sinefungin was designed and synthesized, and probed for their ability to inhibit EHMT1 and EHMT2. This led to a highly potent inhibitor 4d with a K i of 5 nM at EHMT1 and 24 nM at EHMT2. There was variation in the activity of the compounds and most of the compounds displayed little inhibition.
Conclusion
Here we exchanged the α-amino acid moiety and demonstrated that it is not essential for inhibitory activity at EHMT1/2. Our results indicate that these scaffolds upon further modifications can lead to selective, potent inhibitors of EHMTs and possibly other PKMTs. 
